BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Nuron Biotech 

1 East Uwchlan Avenue
Suite 302
Exton  Pennsylvania  19341  U.S.A.
Phone: 610-968-6700 Fax: 610-968-6650


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
Nuron Biotech Announces Appointment of New Management Team Members and Provides an Update on Commercial Vaccine Meningitec™ 10/17/2013 7:59:39 AM    More...
Nuron Biotech to Present at Biotechnology Industry Organization (BIO) Business Forum® 4/22/2013 9:25:03 AM    More...
Nuron Biotech Selected to Present at Future Leaders in the Biotech Industry Conference 4/2/2013 10:39:22 AM    More...
Nuron Biotech Receives Pennsylvania Bio's 2013 Deal of the Year Award for Advancing Bioscience Industry 3/18/2013 10:04:27 AM    More...
Nuron Biotech Raises $80 Million 12/20/2012 6:38:23 AM    More...
Nuron Biotech Buys Pfizer Inc. (PFE)'s Preventive Vaccine Meningitec 12/10/2012 7:53:20 AM    More...
Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis 11/13/2012 9:29:15 AM    More...
Nuron Biotech Expands Portfolio With Exclusive, Worldwide License for an Amyloid Beta 42 DNA Vaccine Candidate for Alzheimer's Disease 4/9/2012 7:59:58 AM    More...
Nuron Biotech Expands Portfolio With License of Therapeutic and Prophylactic Hepatitis Vaccine Candidates 3/5/2012 11:59:25 AM    More...
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market 1/13/2012 6:30:43 AM    More...
12

//-->